Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of cancer-type amino acid transporter LAT1 suppresses B16-F10 melanoma metastasis in mouse models
Zitong Shi, Kazuko Kaneda‐Nakashima, Ryuichi Ohgaki, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 11

Showing 11 citing articles:

Amino acid transporters within the solute carrier superfamily: Underappreciated proteins and novel opportunities for cancer therapy
Kiavash Hushmandi, Behzad Einollahi, Seyed Hassan Saadat, et al.
Molecular Metabolism (2024) Vol. 84, pp. 101952-101952
Open Access | Times Cited: 13
Assessment of thermal and solvent stable SPME fibers for metabolomics studies performed in living systems
Kübra Kahremanoğlu, Karol Jaroch, Paulina Szeliska, et al.
Talanta (2025), pp. 127646-127646
Closed Access | Times Cited: 1
Structure–activity characteristics of phenylalanine analogs selectively transported by L-type amino acid transporter 1 (LAT1)
Sihui Chen, Chunhuan Jin, Ryuichi Ohgaki, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Boronophenylalanine‐Containing Polydopamine Nanoparticles for Enhanced Combined Boron Neutron Capture Therapy and Photothermal Therapy for Melanoma Treatment
Liqun Dai, Tao Wang, Siming Zhou, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 38
Closed Access | Times Cited: 4
CD44v, S1PR1, HER3, MET and cancer‐associated amino acid transporters are promising targets for the pancreatic cancers characterized using mAb
Takashi Nakano, Kouki Okita, Shogo Okazaki, et al.
FEBS Open Bio (2025)
Open Access
Pharmacological and structural insights into nanvuranlat, a selective LAT1 (SLC7A5) inhibitor, and its N-acetyl metabolite with implications for cancer therapy
Chunhuan Jin, Xinyu Zhou, Minhui Xu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Advancements, challenges, and future frontiers in covalent inhibitors and covalent drugs: A review
Muhammad Salman Hameed, Hongxuan Cao, Li Guo, et al.
European Journal of Medicinal Chemistry Reports (2024), pp. 100217-100217
Open Access | Times Cited: 2
Metabolic insights into tumor lymph node metastasis in melanoma
Jiayi Huang, Zixu Gao, Jiangying Xuan, et al.
Cellular Oncology (2024)
Closed Access | Times Cited: 2
Impact of genetic variants in the solute carrier (SLC) genes encoding drug uptake transporters on the response to anticancer chemotherapy
José J.G. Marı́n, María A. Serrano, Elisa Herráez, et al.
Cancer Drug Resistance (2024)
Open Access | Times Cited: 1
The complex interplay between redox dysregulation and mTOR signaling pathway in cancer: A rationale for cancer treatment
Christophe Glorieux, Cinthya Enríquez, Pedro Buc Calderón
Biochemical Pharmacology (2024) Vol. 232, pp. 116729-116729
Closed Access | Times Cited: 1
Development of LAT1-Selective Nuclear Medicine Therapeutics Using Astatine-211
Kazuko Kaneda‐Nakashima, Yoshifumi Shirakami, K Hisada, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12386-12386
Open Access
Page 1

Scroll to top